Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2710.2008.00924.x/fullpdf
Reference38 articles.
1. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology;Rizzo;Blood,2002
2. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update;Bokemeyer;European Journal of Cancer,2007
3. 3.National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: cancer- and treatment-related anemia (2008) Version 1. Available at: http://www.nccn.org/professionals/physician_gls/PDF/anemia.pdf (accessed 14 March 2008).
4. Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis;Bohlius;Journal of the National Cancer Institute,2005
5. Cancer-related anemia and recombinant human erythropoietin an updated overview;Bohlius;Nature Clinical Practice Oncology,2006
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency;Advances in Therapy;2020-04-15
2. Position paper on management of iron deficiency in adult cancer patients;Expert Review of Hematology;2017-07-03
3. Current misconceptions in diagnosis and management of iron deficiency;BLOOD TRANSFUS-ITALY;2017
4. Combination with intravenous iron supplementation or doubling erythropoietin dose for patients with chemotherapy-induced anaemia inadequately responsive to initial erythropoietin treatment alone: study protocol for a randomised controlled trial;BMJ Open;2016-10
5. Iron sucrose – characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas;Expert Opinion on Pharmacotherapy;2014-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3